{"organizations": [], "uuid": "10fb7aceac7ee8fcf03cf52fa39feed750ef76a9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-nightstar-therapeutics-reports-201/brief-nightstar-therapeutics-reports-2017-financial-results-idUSASC09UT7", "country": "US", "domain_rank": 408, "title": "BRIEF-Nightstar Therapeutics Reports 2017 Financial Results", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-04T01:08:00.000+03:00", "replies_count": 0, "uuid": "10fb7aceac7ee8fcf03cf52fa39feed750ef76a9"}, "author": "", "url": "https://www.reuters.com/article/brief-nightstar-therapeutics-reports-201/brief-nightstar-therapeutics-reports-2017-financial-results-idUSASC09UT7", "ord_in_thread": 0, "title": "BRIEF-Nightstar Therapeutics Reports 2017 Financial Results", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "nightstar therapeutics plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 4 (Reuters) - Nightstar Therapeutics PLC:\n* REPORTS 2017 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS * ‍AS OF DEC 31, 2017, CASH AND CASH EQUIVALENTS TOTALED $129.4 MILLION, VERSUS $10.1 MILLION AT DEC 31, 2016​ Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-04T01:08:00.000+03:00", "crawled": "2018-04-04T02:18:41.005+03:00", "highlightTitle": ""}